Luminex Corporation
12212 Technology Boulevard
Austin,
TX 78727
United States - Map
Phone: 512-219-8020
Fax: 512-219-5195
Web Site: http://www.luminexcorp.com
| Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for applications in the life sciences and diagnostic industries in the United States. It offers xMAP technology, an open architecture and multiplexing technology, which allows simultaneous analysis of up to 100 bioassays on a single drop of fluid by reading biological tests on the surface of microscopic polystyrene beads called microspheres. The companys xMAP technology is used in various segments of the life sciences industry, which includes the fields of drug discovery and development, clinical diagnostics, genetic analysis, bio-defense, protein analysis, and biomedical research. It operates in two segments, Technology and Assay. The Technology segment offers instruments, such as compact analyzers that integrate fluidics, optics, and digital signal processing; consumables comprising microspheres and sheath fluid; and LXR Software Developers Kit, a software interface for reading xMAP based assays on Luminex hardware. The Assay segment involves in the development and sale of assays on xMAP technology for use on Luminexs installed base of systems. It offers kits, which are the combination of chemical and biological reagents, and the companys proprietary bead technology used to perform diagnostic and research assays on samples. Luminex Corporation serves pharmaceutical companies, clinical laboratories, research institutions, and medical institutions. The company was founded in 1995 and is based in Austin, Texas. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Patrick J. Balthrop Sr., 52
Chief Exec. Officer, Pres, Director, Member of Exec. Committee and Member of Devel. & Strategy Committee |
$
916.00K |
$
0 | Mr. Harriss T. Currie , 47
Chief Financial Officer, Principal Accounting Officer, VP of Fin. and Treasurer |
$
382.00K |
$
0 | Mr. Russell W. Bradley , 45
VP of Bus. Devel. & Strategic Planning |
$
344.00K |
$
0 | Mr. Gregory J. Gosch , 46
VP of Luminex Bioscience Group |
$
346.00K |
$
0 | Mr. Michael F. Pintek ,
Sr. VP of Operations |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
2.03% Nasdaq 
0.63 (4.44%) 
Profile
